000 01391 a2200373 4500
005 20250516230635.0
264 0 _c20150928
008 201509s 0 0 eng d
022 _a1365-2125
024 7 _a10.1111/bcp.12497
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCarls, Alexandra
245 0 0 _aSystemic exposure of topical erythromycin in comparison to oral administration and the effect on cytochrome P450 3A4 activity.
_h[electronic resource]
260 _bBritish journal of clinical pharmacology
_cDec 2014
300 _a1433-40 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdministration, Oral
650 0 4 _aAdministration, Topical
650 0 4 _aAdult
650 0 4 _aArea Under Curve
650 0 4 _aCytochrome P-450 CYP3A
_xmetabolism
650 0 4 _aCytochrome P-450 CYP3A Inhibitors
_xpharmacology
650 0 4 _aErythromycin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
700 1 _aJedamzik, Julia
700 1 _aWitt, Lukas
700 1 _aHohmann, Nicolas
700 1 _aBurhenne, Juergen
700 1 _aMikus, Gerd
773 0 _tBritish journal of clinical pharmacology
_gvol. 78
_gno. 6
_gp. 1433-40
856 4 0 _uhttps://doi.org/10.1111/bcp.12497
_zAvailable from publisher's website
999 _c24113528
_d24113528